Fundraising September 15, 2024 – October 1, 2024 About fundraising

Rogaratinib: A potent and selective pan-FGFR inhibitor with...

  • Main
  • 2019 / 02
  • Rogaratinib: A potent and selective pan-FGFR inhibitor with...

Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models

Grünewald, Sylvia, Politz, Oliver, Bender, Sebastian, Héroult, Mélanie, Lustig, Klemens, Thuss, Uwe, Kneip, Christoph, Kopitz, Charlotte, Zopf, Dieter, Collin, Marie-Pierre, Boemer, Ulf, Ince, Stuart,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.32224
Date:
February, 2019
File:
PDF, 2.06 MB
english, 2019
Conversion to is in progress
Conversion to is failed